查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386257

震盪市場報告：2030 年趨勢、預測與競爭分析

Concussion Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

震盪趨勢和預測

預計到 2030 年，全球震盪市場將達到約 97.8 億美元，2024 年至 2030 年年複合成長率為 3.9%。這個市場的主要促進因素是運動和道路事故造成的傷害數量不斷增加、人口高齡化加劇以及全球研發活動的增加。全球腦震盪市場前景廣闊，醫院/診所市場和診斷中心市場蘊藏商機。

震盪市場洞察

Lucintel 預測，由於全球腦損傷病例數量不斷增加，診斷預計將在預測期內實現高速成長。

由於先進的醫療設備、有利的報銷計劃以及越來越多的人更喜歡醫院作為治療方法，醫院和診所將繼續成為市場的最大部分。

由於腦損傷引起的腦震盪發生率上升以及政府機構和私人公司提高意識的努力，預計北美地區在預測期內將經歷最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個細分市場成長較快？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球震盪市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球震盪市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球震盪市場
    • 診斷
    • 治療
  • 以最終用途分類的全球震盪市場
    • 醫院和診所
    • 診斷中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球震盪市場按地區分類
  • 北美震盪市場
  • 歐洲震盪市場
  • 亞太震盪市場
  • 其他區域震盪市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球震盪市場成長機會
    • 按最終用途分類的全球震盪市場成長機會
    • 按地區分類的全球震盪市場成長機會
  • 全球震盪市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球震盪市場的產能
    • 全球震盪市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Zydus Cadila
  • Novartis
  • Lupin
  • Mylan
  • Medtronic
  • Pfizer
  • Sanofi
  • InfraScan
  • Oculogica
  • Raumedic
簡介目錄

Concussion Trends and Forecast

The future of the global concussion market looks promising with opportunities in the hospital & clinic and diagnostic center markets. The global concussion market is expected to reach an estimated $9.78 billion by 2030 with a CAGR of 3.9% from 2024 to 2030. The major drivers for this market are rising number of injuries from sports and road accidents, increasing aging population, and growing research and development activities across the globe.

A more than 150-page report is developed to help in your business decisions.

Concussion by Segment

The study includes a forecast for the global concussion by type, end use, and region.

Concussion Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnosis
  • Treatment

Concussion Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

Concussion Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Concussion Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies concussion companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the concussion companies profiled in this report include-

  • Zydus Cadila
  • Novartis
  • Lupin
  • Mylan
  • Medtronic
  • Pfizer
  • Sanofi
  • Infrascan
  • Oculogica
  • Raumedic
  • BioDirection

Concussion Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing number of brain injury cases across the globe.

Within this market, hospitals & clinics will remain the largest segment due to avialability of advanced medical equipment and favorable reimbursement facilities and increasing preference of people towards hospitals as a preffered mode of treatment.

North America is expected to witness highest growth over the forecast period due to the rising incidence of concussions stemming from brain injuries along with increasing awareness efforts by government organizations and private firms.

Features of the Global Concussion Market

Market Size Estimates: Concussion market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Concussion Market size by type, end use, and region in terms of value ($B).

Regional Analysis: Concussion market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the concussion market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the concussion market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the concussion market size?

Answer: The global concussion market is expected to reach an estimated $9.78 billion by 2030.

Q.2 What is the growth forecast for concussion market?

Answer: The global concussion market is expected to grow with a CAGR of 3.9% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the concussion market?

Answer: The major drivers for this market are rising number of injuries from sports and road accidents, increasing aging population, and growing research and development activities across the globe.

Q4. What are the major segments for concussion market?

Answer: The future of the concussion market looks promising with opportunities in the hospital & clinic and diagnostic center markets.

Q5. Who are the key Concussion Market companies?

Answer: Some of the key concussion companies are as follows:

  • Zydus Cadila
  • Novartis
  • Lupin
  • Mylan
  • Medtronic
  • Pfizer
  • Sanofi
  • InfraScan
  • Oculogica
  • Raumedic

Q6. Which concussion market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing number of brain injury cases across the globe.

Q7. In concussion market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the rising incidence of concussions stemming from brain injuries along with increasing awareness efforts by government organizations and private firms.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the concussion market by type (diagnosis and treatment), end use (hospitals and clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Concussion Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Concussion Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Concussion Market by Type
    • 3.3.1: Diagnosis
    • 3.3.2: Treatment
  • 3.4: Global Concussion Market by End Use
    • 3.4.1: Hospitals & Clinics
    • 3.4.2: Diagnostic Centers
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Concussion Market by Region
  • 4.2: North American Concussion Market
    • 4.2.2: North American Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.3: European Concussion Market
    • 4.3.1: European Concussion Market by Type: Diagnosis and Treatment
    • 4.3.2: European Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Concussion Market
    • 4.4.1: APAC Concussion Market by Type: Diagnosis and Treatment
    • 4.4.2: APAC Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Concussion Market
    • 4.5.1: ROW Concussion Market by Type: Diagnosis and Treatment
    • 4.5.2: ROW Concussion Market by End Use: Hospitals & Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Concussion Market by Type
    • 6.1.2: Growth Opportunities for the Global Concussion Market by End Use
    • 6.1.3: Growth Opportunities for the Global Concussion Market by Region
  • 6.2: Emerging Trends in the Global Concussion Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Concussion Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Concussion Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Zydus Cadila
  • 7.2: Novartis
  • 7.3: Lupin
  • 7.4: Mylan
  • 7.5: Medtronic
  • 7.6: Pfizer
  • 7.7: Sanofi
  • 7.8: InfraScan
  • 7.9: Oculogica
  • 7.10: Raumedic